“This is one of those studies at ACC that I think is potentially practice changing,” said Kim Eagle, director of the Frankel Cardiovascular Center at the University of Michigan who wasn’t involved in the trial. It’s “a very important landmark study that will change the way patients who are currently managed with [heart attacks] are cared for.”
Add comment